- Home
- MTLS vs ATAI Comparison
MTLS vs ATAI Comparison
Compare MTLS & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- ATAI
- Stock Information
- Founded
- MTLS 1990
- ATAI 2018
- Country
- MTLS Belgium
- ATAI Germany
- Employees
- MTLS N/A
- ATAI N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- ATAI Health Care
- Exchange
- MTLS Nasdaq
- ATAI Nasdaq
- Market Cap
- MTLS N/A
- ATAI 282.6M
- IPO Year
- MTLS 2014
- ATAI 2021
- Fundamental
- Price
- MTLS $5.51
- ATAI $1.41
- Analyst Decision
- MTLS
- ATAI Strong Buy
- Analyst Count
- MTLS 0
- ATAI 3
- Target Price
- MTLS N/A
- ATAI $10.50
- AVG Volume (30 Days)
- MTLS 131.3K
- ATAI 1.4M
- Earning Date
- MTLS 04-24-2025
- ATAI 05-19-2025
- Dividend Yield
- MTLS N/A
- ATAI N/A
- EPS Growth
- MTLS 43.31
- ATAI N/A
- EPS
- MTLS 0.17
- ATAI N/A
- Revenue
- MTLS $291,295,936.00
- ATAI $308,000.00
- Revenue This Year
- MTLS $6.55
- ATAI $65.58
- Revenue Next Year
- MTLS $9.21
- ATAI N/A
- P/E Ratio
- MTLS $30.75
- ATAI N/A
- Revenue Growth
- MTLS 6.16
- ATAI N/A
- 52 Week Low
- MTLS $3.93
- ATAI $1.03
- 52 Week High
- MTLS $9.69
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- MTLS 63.19
- ATAI 44.57
- Support Level
- MTLS $5.21
- ATAI $1.36
- Resistance Level
- MTLS $5.43
- ATAI $1.54
- Average True Range (ATR)
- MTLS 0.20
- ATAI 0.09
- MACD
- MTLS 0.09
- ATAI -0.00
- Stochastic Oscillator
- MTLS 93.39
- ATAI 0.00
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.